Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Haleon PLC Sponsored ADR ( (HLN) ).
On August 15, 2025, Haleon PLC announced the purchase and cancellation of 1,399,293 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction reflects the company’s strategic move to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares with voting rights to 8,971,026,290, which may impact shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
Haleon PLC’s overall stock score of 65 reflects a mixed outlook. Strong financial performance and strategic investments are offset by bearish technical signals and regional sales challenges, particularly in North America. The company’s valuation is moderate, aligning with its growth prospects. Continued focus on innovation and market expansion could enhance its position, but near-term challenges need to be addressed.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers products in six major categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Its portfolio includes well-known brands like Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 13,826,065
Technical Sentiment Signal: Hold
Current Market Cap: $43.47B
Find detailed analytics on HLN stock on TipRanks’ Stock Analysis page.